This relationship may be partly explained by the characteristics of participants with moderate or severe insulin resistance, who often present with systemic inflammation—marked by elevated levels of white blood cells, neutrophils, and plasma interleukin-6—and dyslipidemia, characterized by high triglycerides and low HDL cholesterol. This evidence concerns the gene IL6 and metabolic syndrome.